FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.
暂无分享,去创建一个
Minoru Yoshida | Hidenori Nakajima | Akito Tanaka | Akihisa Matsuyama | Norikazu Nishino | Makoto Nishiyama | M. Nishiyama | S. Horinouchi | Minoru Yoshida | Akihisa Matsuyama | N. Nishino | Y. Komatsu | Kun-Hyung Lee | N. Kobashi | Sueharu Horinouchi | R. Furumai | H. Nakajima | A. Tanaka | Nobuyuki Kobashi | Ryohei Furumai | Kun-Hyung Lee | Yasuhiko Komatsu
[1] R. Huber,et al. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. , 1995, European journal of biochemistry.
[2] Structure of the lysosomal sphingolipid activator protein 1 by homology with influenza virus neuraminidase. , 1988, Biochemical and biophysical research communications.
[3] J. Essigmann,et al. Mechanisms of resistance to cisplatin. , 2001, Mutation research.
[4] B. Matthews,et al. Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analogue mercaptans. , 1982, Biochemistry.
[5] T. Tsuruo,et al. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity. , 2001, Cancer research.
[6] S. Doglia,et al. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein. , 2000, European journal of cancer.
[7] S. Inoue,et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.
[8] H. Kwon,et al. Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis , 2002, International journal of cancer.
[9] J. Powers,et al. Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography. , 1979, Biochemistry.
[10] S. Meng,et al. p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .
[11] C. Tribioli,et al. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.
[12] A. Wolffe,et al. Activators and repressors: making use of chromatin to regulate transcription , 1997, Genes to cells : devoted to molecular & cellular mechanisms.
[13] N. Mutoh,et al. Isolation of mutants of Schizosaccharomyces pombe unable to synthesize cadystin, small cadmium-binding peptides. , 1988, Biochemical and biophysical research communications.
[14] S. Minucci,et al. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.
[15] S. Schreiber,et al. A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.
[16] C. Glass,et al. Co-activators and co-repressors in the integration of transcriptional responses. , 1998, Current opinion in cell biology.
[17] Bing-he Xu,et al. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067. , 1992, Cancer research.
[18] M. Yoshida,et al. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. , 1998, Experimental cell research.
[19] I. Kawamura,et al. FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced by Chromobacterium violaceum No. 968. Part 3. Antitumor Activities on Experimental Tumors in Mice. , 1994 .
[20] G. Meersma,et al. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. , 1992, Cancer research.
[21] E. Sausville,et al. P21-dependent G 1 arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228 , 2000, British Journal of Cancer.
[22] D. Faller,et al. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[23] S. Horinouchi,et al. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[24] T. Fojo,et al. Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. , 2001, The Journal of clinical endocrinology and metabolism.
[25] B. Matthews,et al. Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis. , 1982, Biochemistry.
[26] L. Neckers,et al. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. , 2002, Journal of the National Cancer Institute.
[27] R. Huber,et al. The X‐ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. , 1994, The EMBO journal.
[28] M. Grunstein,et al. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Meng,et al. WAF 1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .
[30] J. Powers,et al. Inhibition of thermolysin and carboxypeptidase A by phosphoramidates. , 1979, Biochemistry.
[31] M. Okuhara,et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. , 1994, The Journal of antibiotics.
[32] M. Okuhara,et al. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. , 1994, Bioscience, biotechnology, and biochemistry.
[33] W. Wilson,et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. , 2001, Blood.
[34] B Rubin,et al. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.
[35] T. Ishikawa,et al. The Human Multidrug Resistance-Associated Protein (MRP) Gene Family: From Biological Function to Drug Molecular Design , 2000, Clinical chemistry and laboratory medicine.
[36] R. Huber,et al. X‐ray Structures of Human Neutrophil Collagenase Complexed with Peptide Hydroxamate and Peptide Thiol Inhibitors , 1995 .
[37] L. Guarente,et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.
[38] A. Verdel,et al. Functional significance of histone deacetylase diversity. , 2001, Current opinion in genetics & development.
[39] M. Yoshida,et al. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Yoshida,et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. , 1993, The Journal of biological chemistry.
[41] S. Horinouchi,et al. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase , 1999, Oncogene.
[42] S. Waxman,et al. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. , 1999, Blood.
[43] P. Marks,et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.
[44] N. Borkakoti,et al. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor , 1994, Nature Structural Biology.
[45] S. Meng,et al. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.